Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma

Glioblastoma (GB) is the most frequent primary brain tumor in adults with a dismal prognosis despite aggressive treatment including surgical resection, radiotherapy and chemotherapy with the alkylating agent temozolomide. Thus far, the successful implementation of the concept of targeted therapy whe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Neuropathol Commun
Main Authors: Ronellenfitsch, Michael W., Zeiner, Pia S., Mittelbronn, Michel, Urban, Hans, Pietsch, Torsten, Reuter, Dirk, Senft, Christian, Steinbach, Joachim P., Westphal, Manfred, Harter, Patrick N.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6102828/
https://ncbi.nlm.nih.gov/pubmed/30129426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-018-0583-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados